Back

The clinical significance of misleading troponin elevations: is macrotroponin a culprit for unnecessary invasive coronary angiography?

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Alexander Holst Kronborg

Herlev and Gentofte Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Clonal Hematopoiesis of Indeterminate Potential (CHIP) mutations in patients with coronary artery disease
Doctor N. Senguttuvan (Chennai, IN)
Abstract Slides Video
Presentation thumbnail
Albumin-based inflammation scores with integrated thrombotic markers outperform conventional predictors for mortality in acute coronary syndrome and atrial fibrillation
Doctor H. Liang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Novel admission hyperglycaemia markers as predictors of poor outcomes following percutaneous coronary interventions: a dose-response meta-analysis
Mr P. Siahaan (Surabaya, ID)
Abstract Slides Video
Presentation thumbnail
Diagnostic and prognostic utility of neutrophil-to-lymphocyte ratio as a biomarker in patients with acute chest pain
Mr B. Okamura (Basel, CH)
Abstract Slides Video
Presentation thumbnail
High frequency of macrotroponin i in the upper troponin range of a healthy reference population but no variation by age or sex
Mrs N. Strandkjaer (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Assay of macrotroponin I not complexed with troponin T: effect on the performance of troponin T to predict myocardial infarction
thumbnail
Congress Presentation
The hidden role of cardiac troponin interferents in diagnosis and clinical management of myocarditis: a single center experience.
thumbnail
Congress Presentation
The incremental value of non-necrosis biomarkers to risk stratification in acute chest pain, with MI excluded: the first prospective long term cohort study in the high sensitive troponin era

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources